Klein Matthew B. sold PTCT
August 4, 2026 · Form 4 insider transaction
Klein Matthew B. sold 10,292 shares of PTC Therapeutics, Inc. at $68.57 per share, a transaction worth $705.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
10,292
Price
$68.57
Total value
$705.7K
InsiderKlein Matthew B.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 4, 2026
Filing dateAugust 6, 2026
Shares owned after383,868
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of the 25,000 RSUs from an August 1, 2025 grant of 75,000 RSUs.; Includes 162 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2026.